Software Healthcare Sector

Halozyme Therapeutics

Market Cap: US$9.4b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally.

Bruker

Market Cap: US$9.4b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.

Kymera Therapeutics

Market Cap: US$9.3b

A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.

Alkermes

Market Cap: US$9.1b

A biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

Praxis Precision Medicines

Market Cap: US$8.9b

A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance in the United States.

Glaukos

Market Cap: US$8.7b

An ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally.

Hims & Hers Health

Market Cap: US$8.5b

Operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.

Protagonist Therapeutics

Market Cap: US$8.5b

Operates as a discovery and development company in the United States.

Vaxcyte

Market Cap: US$8.4b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Qiagen

Market Cap: US$8.3b

Provides sample to insight solutions that transform biological samples into molecular insights worldwide.

Hisamitsu Pharmaceutical

Market Cap: US$8.2b

Manufactures and sells pharmaceuticals in Japan.

Repligen

Market Cap: US$8.0b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

HealthEquity

Market Cap: US$8.0b

Provides technology-enabled services platforms to consumers and employers in the United States.

Immunovant

Market Cap: US$8.0b

A clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases.

Bio-Rad Laboratories

Market Cap: US$7.9b

Develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally.

Rhythm Pharmaceuticals

Market Cap: US$7.8b

A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United States and internationally.

Mirum Pharmaceuticals

Market Cap: US$7.7b

A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

TG Therapeutics

Market Cap: US$7.6b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Spyre Therapeutics

Market Cap: US$7.5b

A clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD) and rheumatic diseases.

Sonic Healthcare

Market Cap: AU$10.5b

Offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally.

Lantheus Holdings

Market Cap: US$7.2b

Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.

Ramsay Health Care

Market Cap: AU$10.2b

Owns and operates hospitals in Australia and internationally.

Avantor

Market Cap: US$7.0b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

PACS Group

Market Cap: US$7.0b

Through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States.

Liquidia

Market Cap: US$7.0b

A biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States.

PTC Therapeutics

Market Cap: US$6.9b

A biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally.

Cogent Biosciences

Market Cap: US$6.6b

A clinical-stage biotechnology company, focuses on developing precision therapies for genetically defined diseases.

Scholar Rock Holding

Market Cap: US$6.6b

A biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases.

Hinge Health

Market Cap: US$6.5b

Focuses on building a health system that scales and automates the delivery of care using technology.

Chemed

Market Cap: US$6.5b

Provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States.

Ligand Pharmaceuticals

Market Cap: US$6.3b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

CG Oncology

Market Cap: US$6.2b

A late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States.

Twist Bioscience

Market Cap: US$6.2b

Manufactures and sells synthetic DNA-based products.

Bausch + Lomb

Market Cap: US$6.1b

Operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally.

Teleflex

Market Cap: US$5.9b

Designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally.

Xenon Pharmaceuticals

Market Cap: US$5.9b

A neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders.